Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Galderma, Medigene deal

August 4, 2008 7:00 AM UTC

MediGene granted Galderma European rights to Oracea doxycycline, which the EC approved to treat rosacea last week. MediGene, which announced in June that it would exit its dermatology business, will ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article